GlassScriptPhysician profile
Jose A Montero
NPI 1699715748
$798.02
in general payments reported to CMS, 2019-2025
9 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $286 · 2021: $110 · 2022: $28.14 · 2024: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $374.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $374.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Biomerieux INC | $374.05 | 2024 | |
| Sanofi-Aventis U.S. LLC | $109.76 | 2021 | |
| Merck Sharp & Dohme LLC | $103.59 | 2019 | |
| Gilead Sciences, INC. | $78.47 | 2019 | |
| Melinta Therapeutics, LLC | $49.77 | 2019 | |
| Mannkind Corporation | $28.14 | 2022 | |
| Astellas Pharma US INC | $19.30 | 2019 | |
| Viiv Healthcare Company | $17.58 | 2019 | |
| Allergan, INC. | $17.36 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jose Montero listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.